From: Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost
Dermatitis
Grade 1
6 (16%)
Grade 2
31 (84%)
Mucositis
9 (24%)
18 (49%)
Grade 3
10 (27%)
Dysphagia
5 (14%)
22 (59%)